Trial intelligence / Profile preview

External Oblique Intercostal Block Versus Port-Site Infiltration for Postoperative Analgesia in Laparoscopic Cholecystectomy

NCT07164664Completed

Sponsor
Ondokuz Mayıs University
Start
Sep 2025
Primary completion
Jan 2026
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Ondokuz Mayıs University. Primary endpoint: Cumulative opioid consumption in the first 24 hours after surgery. Started Sep 2025; status: completed.

02

Drugs

bupivacaine hydrochloride 0.75% injection
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT07164664.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07164664.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call